At least seven companies are slated to report earnings this week. Myriad Genetics Inc. (NASDAQ:MYGN) and PDL BioPharma Inc. (NASDAQ:PDLI) are both expected to report double-digit declines in EPS. Myriad's EPS for the fiscal 4Q ended June 30